Sonoma Pharmaceuticals, Inc.
SNOACIK 0001367083 · Surgical & Medical Instruments & Apparatus · Nasdaq
- Oculus Innovative Sciences, Inc. (until 2016-12-02)
Revenue (TTM)
$17.53M
+36.7% YoY
FY Jun 2026
Net Income (TTM)
−$3.52M
+8.2% YoY
FY Jun 2026
EPS Diluted (TTM)
−$2.19
+32.3% YoY
FY Jun 2026
Gross Margin
37.1%
FY Jun 2026
Operating Margin
-17.9%
FY Jun 2026
Net Margin
-20.1%
FY Jun 2026
Free Cash Flow (TTM)
−$4.83M
FY Jun 2026
Cash
$2.4M
FY Jun 2026
Total Debt
$237K
FY Jun 2026
Shares Outstanding
4.79M sh
FY Jun 2026